Ultimovacs Competitors and Similar CompaniesClear all
Ultimovacs's competitors and similar companies include La Jolla Pharmaceutical Company, Pharmacyclics, Arcus Biosciences and TRON.
 La Jolla Pharmaceutical Company La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. |  Arcus Biosciences Arcus Biosciences is a biotech company that visions to create new cancer therapeutics through the use of emerging insights in immunology. |  TRON TRON Mainz is a biopharmaceutical research organization that offers diagnostics and drugs for the treatment of cancer and other severe diseases. | ||
Founding Date | Founding Date 2011 | Founding Date 1989 | Founding Date 1991 | Founding Date 2015 | Founding Date 2010 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Oslo, NO HQ Uppsala, SE | Locations San Diego, US HQ San Diego, US San Diego, US | Locations Sunnyvale, US HQ | Locations Hayward, US HQ | Locations Mainz, DE HQ |
Employees | Employees 19 | Employees 9047% decrease | Employees 6551% decrease | Employees 500502% increase | Employees 1903% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 171.2 m | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $75.7m (FY, 2021) | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) $247m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $40.4m (FY, 2014) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $689.3m (FY, 2014) | Gross profit N/A | Gross profit N/A |
Net income | Net income (kr140.7m) (FY, 2025) | Net income $19.7m (FY, 2021) | Net income $86.1m (FY, 2014) | Net income ($353m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 22.9m | Total funding raised N/A | Total funding raised $ 70m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
La Jolla Pharmaceutical Company
HQ
San Diego, US
Employees
90↓ 47% decrease
La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.
View companyPharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View companyArcus Biosciences
HQ
Hayward, US
Employees
500
Arcus Biosciences is a biotech company that visions to create new cancer therapeutics through the use of emerging insights in immunology.
View companyTRON
HQ
Mainz, DE
Employees
190↑ 3% increase
TRON Mainz is a biopharmaceutical research organization that offers diagnostics and drugs for the treatment of cancer and other severe diseases.
View company